Dimension Inx, a biofabrication company developing regenerative medical implants that repair tissues and organs, has raised $3.175M to close its Series Seed financing round, led by KdT Ventures. The round also saw the participation of Better Ventures and Revolution's Rise of the Rest Seed Fund.

Dimension Inx is an emerging leader in biofabrication in medicine. The firm's 3D-Painting Materials Design and Manufacturing System offers the versatility, manufacturability, and affordability necessary for widespread adoption of tissue-engineered regenerative medical products.